Kerr Douglas, Chief Officer of Dyne Therapeutics DYN, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $76.7K. The latest trade was on 06/16.

KD

KD

Kerr Douglas

Chief Medical Officer

Company

Dyne Therapeutics DYN

First filing

23/01/18

Trades

38 trades

Buys / sales

0 / 8

12-month net buying

−$76.7K

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	06/16	06/17	887 sh	$18.33	$16,258.71	−0.5%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	05/13	05/14	1,564 sh	$18.36	$28,715.04	−0.9%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	03/05	03/06	904 sh	$14.90	$13,469.6	−0.5%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/12/05	25/12/05	880 sh	$20.72	$18,233.6	−1.0%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/09/04–25/09/05	25/09/08	4,425 sh2 trades	$13.30avg.	$58,841.97	−4.8%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/06/05	25/06/06	1,342 sh	$13.35	$17,915.7	−1.4%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/03/05	25/03/07	1,343 sh	$11.83	$15,887.69	−1.4%